Skip to content

Effect of probiotics and/or synbiotics on intestinal environment in healthy adults.

Effect of probiotics and/or synbiotics on intestinal environment in healthy adults. - Effect of probiotics and/or synbiotics on intestinal environment.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029088
Enrollment
45
Registered
2019-04-01
Start date
2017-09-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake of drink containing high-dose bifidobacterium for 4 weeks - Washout 4 weeks. Intake of drink containing low-dose bifidobacterium for 4 weeks - Washout 4 weeks. Intake of drink containing bifido

Sponsors

Ezaki Glico Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects whose defecation frequency is more than five times per week.

Exclusion criteria

Exclusion criteria: 1. Subjects regularly use intestinal drugs and laxatives (including strong laxatives). 2. Subjects habitually consume higher amount of alcohol. 3. Subjects who can't stop intake food containing bifidobacteria, and/or enhanced with oligosaccharide, dietary fiber during this study. 4. Subjects who have serious diseases requiring an urgent treatment, or who accept severe complication. 5. Subjects who have a medical history of diseases or surgeries affecting digestion, absorption and bowel movement. 6. Subjects who have allergy to test food. 7. Subjects who is pregnant or willing to be pregnant or breast-feeding during this study. 8. Subjects who are participated in other clinical trials that intake/apply any of food, drug, and cosmetics.

Design outcomes

Primary

MeasureTime frame
16S rRNA gene based metagenome analysis of gut microbiome

Secondary

MeasureTime frame
Fecal short chain fatty acid concentration, fecal bifidobacteria, defecation frequency

Countries

Japan

Contacts

Public ContactTakashi Mawatari

Ezaki Glico Co., Ltd Institute of health sciences

takashi.mawatari@glico.com0664778425

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026